CRLBF - Cresco Labs Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Cresco Labs Inc.

400 West Erie Street
Suite 110
Chicago, IL 60654
United States
312-929-0993
http://www.crescolabs.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees1,400

Key Executives

NameTitlePayExercisedYear Born
Mr. Charles BachtellCo-Founder, CEO & DirectorN/AN/A1978
Mr. Brian Thomas McCormackCo-Founder & Vice-ChairmanN/AN/A1968
Mr. Joseph Stevens CaltabianoPres, Co-founder & DirectorN/AN/A1977
Mr. Dominic Anthony SergiCo-Founder & DirectorN/AN/A1983
Mr. Robert M. SampsonCo-Founder & DirectorN/AN/A1974
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cresco Labs Inc. cultivates, manufactures, and sells medical cannabis and medical cannabis products in the United States. It offers cannabis in flower, vape pens, and various forms of extracts under the cresco and Reserve brands; precisely-dosed and non-combustible products, including tinctures, capsules, salves, sublingual oils, and transdermal patches under the Remedi brand; culinary-backed and cannabis-infused edibles under the Mindy's Artisanal brand; and fruity confections under the Mindy's Kitchen brand. As of June 12, 2019, it operated 20 dispensaries in Florida. The company is headquartered in Chicago, Illinois.

Corporate Governance

Cresco Labs Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.